Clinical Trial Update: Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bevacizumab with liposomal doxorubicin in women with locally recurrent or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED